SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

StockProfiler.US: Urgent OTCBB Stock Updates for PVSP & ADLS
[August 24, 2010]

StockProfiler.US: Urgent OTCBB Stock Updates for PVSP & ADLS

Boston, MA,, Aug 24, 2010 (M2 PRESSWIRE via COMTEX) -- Pervasip Corp. (OTCBB: PVSP); Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS) Stock Profiler welcomes investors to sign up at www.stockprofiler.us. to subscribe to our FREE newsletter. Please follow our thread on www.twitter.com at StockProfilerUS NOTE: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. To read the news in its entirety, go to the Leader in Market News, Stock Profiler.US, LLC (www.stockprofiler.us) click the Headline Tab, enter the ticker symbol and click the news link.

------------------------------------------- Pervasip Corp. closed at $0.065 Monday, trading 14,833 shares.

Pervasip's Lender Cancels Warrants to Purchase 25 Million Shares of Stock WHITE PLAINS, N.Y., Aug 24, 2010 -- Pervasip Corp. (OTCBB: PVSP), a provider of Voice over Internet Protocol (VoIP) telephone services and smartphone applications, today announced that its lender has again cancelled warrants to purchase 25 million shares of Pervasip common stock.


About Pervasip Through its wholly owned subsidiary, VoX Communications Corp., Pervasip delivers wholesale voice over IP (VoIP) telephone services for the residential and small business markets. VoX differentiates itself through a unique combination of high quality voice services, flexible back-office capabilities and automated provisioning systems. VoX recently entered the mobile VoIP services and applications arena, which is expected to approach 300 million users by 2013. It offers a feature-rich, low-cost, high-quality alternative to traditional phone services. For more information, please visit www.voxcorp.net.

------------------------------------------- Advanced Life Sciences Holdings, Inc. closed at $0.046 Monday, trading 431,103 shares.

Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report CHICAGO, Aug. 24, 2010 -- Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced plans to seek additional government funding for development of its novel, once-daily antibiotic, Restanza (cethromycin) based on a new, high-profile report from the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response recommending independent investment in small innovator companies developing potentially life-saving medical countermeasures.

About Advanced Life Sciences Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of respiratory tract infections including CABP and biodefense pathogens including anthrax, plague and tularemia. For more information, please visit us on the web atwww.advancedlifesciences.com or follow us on twitter at http://twitter.com/advancedlifesci.

------------------------------------------- About StockProfiler.US StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

------------------------------------------- Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com, http://www.fastmoneytalk.com, http://www.markettelegraph.com, http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://stockprofiler.us/Disclaimer.

------------------------------------------- Keywords: pvsp, pvsp stock, pvsp stock news, pvsp stock alerts, pvsp company news, pvsp penny stock, penny stock news, penny stock alerts, penny stock updates, penny stock news updates, penny stock profile CONTACT: Stock Profiler.US Tel: +1 603 424 4420 e-mail: info@stockprofiler.us WWW: http://www.stockprofiler.us ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

[ Back To TMCnet.com's Homepage ]





LATEST VIDEOS

DOWNLOAD CENTER

UPCOMING WEBINARS

MOST POPULAR STORIES





Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy